VitaIntel

VitaIntel is a biomedical AI startup dedicated to transforming cancer care through advanced machine learning technologies. We specialize in analyzing multi-omics data — including genomics, proteomics, and clinical records — to develop predictive models for early cancer detection and personalized treatment. Our vision is to bridge the gap between data science and real-world healthcare by building intelligent tools that assist clinicians in making faster, more accurate, and patient-specific decisions. By leveraging cutting-edge algorithms, we aim to uncover hidden patterns in complex datasets, enabling breakthroughs in oncology and improving patient outcomes worldwide. Founded by a team of passionate engineers and biomedical experts, we aim to redefine how cancer is understood, diagnosed, and treated — one algorithm at a time. Our interdisciplinary approach combines expertise in artificial intelligence, bioinformatics, and clinical research to create scalable solutions tailored to the needs of healthcare providers and patients alike. We are committed to fostering innovation through collaboration with leading research institutions and healthcare organizations. Our ongoing projects include the development of AI-powered diagnostic tools and therapeutic strategies that integrate real-time data for precision medicine. Based in 6th of October, Giza, Egypt, we strive to make a global impact by democratizing access to advanced cancer care technologies.